variou
diethylamino
methyl
hydrazinecarbothioamid
b
diethylamino
methyl
n
hydrazinecarbothioamid
deriv
synthes
compound
screen
cytotox
human
hela
cem
tlymphocyt
well
murin
cell
compound
also
screen
blactamas
inhibitori
activ
antivir
antibacteri
antifung
activ
variou
strain
microorgan
sever
compound
endow
low
micromolar
cytostat
concentr
ic
valu
virtual
equal
potent
melphalan
potent
inhibitor
murin
leukemia
cell
also
inhibitori
human
tlymphocyt
cem
tumor
cell
deriv
diethylamino
methyl
n
hydrazinecarbothioamid
emerg
potent
cytostat
compound
among
test
compound
deriv
show
antivir
activ
hel
cell
cultur
ic
lm
moder
antimicrobi
activ
observ
deriv
encourag
cytostat
antivir
activ
data
provid
adequ
rational
modif
molecular
scaffold
isatin
known
year
recent
found
like
endogen
polyfunct
heterocycl
compound
exhibit
biolog
activ
mammal
somogyi
schiff
base
mannich
base
isatin
known
possess
wide
rang
pharmacolog
properti
includ
antibacteri
pandeya
et
al
sarangapani
reddi
varma
nobl
anticonvuls
sridhar
et
al
varma
et
al
antihiv
pandeya
et
al
pandeya
et
al
pandeya
et
al
b
sriram
et
al
antifung
pandeya
et
al
b
antivir
singh
et
al
anticanc
activ
fig
karki
et
al
karki
et
al
karki
et
al
varieti
util
anticanc
drug
drug
candid
mologni
et
al
beauchard
et
al
zhang
go
andreani
et
al
repres
member
class
sunitinib
sutent
tm
pfizer
inc
current
use
clinic
multitarget
tyrosin
kinas
inhibitor
antiangiogen
activ
fig
sun
et
al
groupsubstitut
potent
inhibitor
pdgfra
low
crossreact
panel
kinas
fig
roth
et
al
current
evalu
phase
iii
clinic
trial
treatment
nonsmal
cell
lung
cancer
clinic
develop
tumor
type
indirubin
identifi
activ
ingredi
tradit
chines
recip
danggui
longhui
wan
use
treatment
chronic
myelogen
leukemia
cml
fig
xiao
et
al
thiosemicarbazon
variou
aldehyd
keton
occupi
special
place
among
organ
ligand
sinc
contain
variou
donor
atom
abl
chang
densiti
depend
start
reagent
reaction
condit
studi
extens
due
import
biolog
activ
karki
et
al
sinc
marboran
found
activ
treatment
smallpox
previou
studi
group
reveal
promis
cytotox
anticonvuls
properti
variou
thiosemicarbazon
fig
karki
et
al
therefor
perform
synthesi
new
thiosemicarbazon
deriv
substitut
evalu
cytotox
antivir
antimicrobi
activ
compound
seri
prepar
methodolog
outlin
scheme
synthesi
diethylamino
methyl
deriv
carri
mannich
base
reaction
diethylamin
presenc
formaldehyd
synthesi
hydrazinecarbothioamid
b
carri
react
diethylamino
methyl
deriv
thiosemicarbazid
n
aryl
thiosemicarbazid
reflux
ethanol
presenc
catalyt
amount
glacial
acet
acid
hnmr
spectroscopi
indic
compound
exist
singl
isom
solut
compound
assay
cytotox
human
hela
cem
tlymphocyt
well
murin
cell
data
summar
tabl
compound
cytostat
among
compound
evalu
tumor
cell
line
ic
low
micromolar
rang
lm
potent
inhibitor
murin
cell
prolifer
also
inhibitori
human
tlymphocyt
cem
hela
cell
prolifer
introduct
r
benzyl
substitut
thiosemicarbazon
deriv
seri
often
led
potent
inhibitor
tumor
cell
prolifer
replac
hydrogen
chlorin
atom
improv
potenti
cytostat
activ
compar
tabl
wherea
replac
chlorin
atom
r
methoxi
group
often
result
mark
equal
potenti
cytostat
activ
replac
hydrogen
atom
r
chlorin
atom
yield
improv
potenc
compar
replac
hydrogen
atom
r
r
chlorin
result
complet
loss
activ
keep
chlorin
atom
r
ch
och
r
result
slight
improv
cytostat
activ
antivir
screen
b
perform
use
mtsbase
cpe
reduct
assay
kumar
et
al
compound
exhibit
moder
antivir
activ
hel
cell
comparison
standard
compound
specif
antivir
effect
note
compound
crfk
mdck
vero
cell
cultur
tabl
synthes
compound
screen
blactamas
inhibitori
activ
result
shown
tabl
compound
name
capabl
inactiv
blactamas
activ
compound
activ
moder
compar
standard
potassium
clavulan
titl
compound
also
screen
antibacteri
activ
aureu
b
subtili
k
pneumonia
e
coli
p
vulgari
typhi
antifung
activ
niger
c
albican
exhibit
moder
antimicrobi
activ
tabl
reagent
obtain
sigmaaldrich
mumbai
loba
chemi
mumbai
solvent
use
studi
dri
distil
use
melt
point
mp
veego
vmppm
digit
melt
point
apparatu
uncorrect
tlc
solvent
benzen
ethanol
uv
spectra
shimadzu
pharmspec
uvvi
spectrophotomet
ir
scheme
reagent
use
follow
ccl
ch
oh
h
na
r
h
cl
ii
c
h
nhhcho
iii
nh
c
nhnh
iv
r
c
h
nhc
nhnh
natur
r
r
substitu
present
tabl
tabl
synthes
intermedi
synthesi
intermedi
accomplish
use
literatur
methodolog
marvel
heir
previous
report
procedur
use
convert
compound
cor
n
arylthiosemicarbazid
requir
prepar
b
prepar
literatur
methodolog
sen
sengupta
lieber
et
al
gener
procedur
synthes
b
found
gener
procedur
synthes
mixtur
diethylamino
methyl
diethylamino
methyl
mol
n
aryl
thiosemicarbazid
mol
acet
acid
ml
ethanol
ml
heat
reflux
reaction
complet
approxim
h
approxim
half
ethanol
remov
vacuo
solut
left
overnight
room
temperatur
precipit
solid
collect
wash
cold
ethanol
recrystal
ethanol
chloroform
give
follow
compound
day
complet
cpe
observ
infect
untreat
viru
control
cytotox
compound
evalu
parallel
antivir
activ
uninfect
cell
express
minimum
cytotox
concentr
caus
microscop
detect
alter
normal
cell
morpholog
hel
hela
crfk
mdck
vero
cell
cytostat
effect
test
compound
murin
leukemia
cell
contain
less
lg
ml
ml
sampl
solut
final
ml
iodin
n
iodin
potassium
iodid
ad
time
decolor
iodin
record
stopwatch
addit
substrat
synthes
compound
standard
potassium
clavulan
blank
determin
use
water
place
sampl
solut
unit
penicillinas
activ
express
pollock
torriani
unit
one
unit
amount
enzym
hydrolyz
lm
sodium
penicillin
g
h
ph
antimicrobi
assay
perform
synthes
compound
cupplat
method
synthes
compound
antibacteri
activ
aureu
b
subtili
k
pneumonia
e
coli
p
vulgari
typhi
antifung
activ
niger
c
albican
activ
express
term
diamet
zone
inhibit
mm
summari
seri
ndiethyl
amino
variou
thiosemicarbazid
moieti
design
synthes
cytotox
synthes
compound
evalu
two
human
cancer
cell
line
cem
hela
murin
leukemia
cell
line
compound
display
excel
cytotox
three
cell
line
test
particular
show
potent
cytotox
cem
cancer
cell
line
preliminari
structureact
relationship
sar
studi
reveal
combin
core
structur
phenyl
thiosemicarbazid
moieti
favor
synthes
compound
screen
cytotox
blactamas
inhibitori
activ
antivir
antibacteri
antifung
activ
variou
strain
microorgan
deriv
show
antivir
activ
hel
cell
cultur
rang
lm
comparison
ic
valu
lm
standard
brivudin
cidofovir
acyclovir
ganciclovir
respect
mild
moder
antimicrobi
activ
observ
encourag
biolog
data
provid
adequ
rational
modif
molecular
scaffold
